Abstract:p53 promotes tumor suppression through its ability to function as a transcriptional factor and is activated by posttranslational modifications that include acetylation. Our earlier study demonstrated that p53 acetylation can enhance its sequence-specific DNA binding in vitro, and this notion was later confirmed in several other studies. However, a recent study has reported that in vitro acetylation of p53 fails to stimulate its DNA binding to large DNA fragments, raising an important issue that requires further investigation. Here, we show that unacetylated p53 is able to bind weakly to its consensus site within the context of large DNA fragments, although it completely fails to bind the same site within short oligonucleotide probes. Strikingly, by using highly purified and fully acetylated p53 proteins obtained from cells, we show that acetylation of the C-terminal domain can dramatically enhance site-specific DNA binding on both short oligonucleotide probes and long DNA fragments. Moreover, endogenous p53 apparently can be fully acetylated in response to DNA damage when both histone deacetylase complex 1 (HDAC1)- and Sir2-mediated deacetylation are inhibited, indicating dynamic p53 acetylation and deacetylation events during the DNA damage response. Finally, we also show that acetylation of endogenous p53 indeed significantly augments its ability to bind an endogenous target gene and that p53 acetylation levels correlate well with p53-mediated transcriptional activation in vivo. Thus, our results clarify some of the confusion surrounding acetylation-mediated effects on p53 binding to DNA and suggest that acetylation of p53 in vivo may contribute, at least in part, to its transcriptional activation functions.

Acetylation-dependent Function of Human Single-Stranded DNA Binding Protein 1

hSSB1 regulates both the stability and the transcriptional activity of p53

SUMOylation Stabilizes Hssb1 and Enhances the Recruitment of NBS1 to DNA Damage Sites

PDHE1α in DNA Damage Repair: a Critical Chromatin Acetylation Regulator

Acetylation of 53BP1 Dictates the DNA Double Strand Break Repair Pathway

Functional Analysis of the Acetylation of Human P53 in DNA Damage Responses

Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair

Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Functional Characterization of TIP60 Sumoylation in UV-irradiated DNA Damage Response.

KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair.

hnRNPA2B1 deacetylation by SIRT6 restrains local transcription and safeguards genome stability

Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents

Histone H1 Acetylation at Lysine 85 Regulates Chromatin Condensation and Genome Stability Upon DNA Damage

Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2

Acetylation of P53 Augments Its Site-Specific DNA Binding Both in Vitro and in Vivo.

The role of human ADA2a in the regulation of p53 acetylation and stability

Abstract 2965: Hssb1 Binds and Protects P21 from Ubiquitin-Mediated Degradation and Positively Correlates with P21 in Human Hepatocellular Carcinomas

Dynamics of the p53 acetylation pathway.

Role of the Histone Acetyl Transferase MOF and the Histone Deacetylase Sirtuins in Regulation of H4K16ac During DNA Damage Repair and Metabolic Programming: Implications in Cancer and Aging

Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination.